We are monitoring the impact of COVID-19 on Competent Cells Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3350
Share on
Share on

Global Competent Cells Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Repot – Segmented By Type, Application, End-User & Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3350
Pages: 175

Global Competent Cells Market Size (2021 to 2026):

The global competent cells market size is valued at USD 1.88 billion in 2021. This value is estimated to grow at a CAGR of 10.40% and reach USD 3.08 billion by 2026. The global competent cells market is developing at a rapid pace.

The cells which can proliferate are made competent to get faster results. The US FDA has approved new guidelines for testing retroviral vector-based human gene therapy for a replication-competent retrovirus, which will boost the research in the field of the competent cell as there is a more important requirement of retrovirus therapy and vaccine. The competent cell technique can be used to create a vaccine for retrovirus. The synthetic biology company SGI-DNA and Gibson Assembly Reagents have launched Vmax X2 competent cells. It is designed to generate two to four times more soluble protein in half of the current reliance on E. coli.

COVID-19 impact on the global competent cells market:

In this time of COVID – 19 pandemic, the competent cell technique can be used in the research as a bacterial artificial chromosome used to study the stature of coronavirus. It could boost the market growth of the competent cell market. The countries in the Asia Pacific, such as India and China, are investing more in the research of competent cell technology.

MARKET DRIVERS:

The global competent cells market is driven by the increasing demand for recombinant DNA technique products.

There are many applications of recombinant DND techniques such as in gene therapy, vaccine production, cancer treatment, and treatment of retrovirus. The advancement in molecular engineering and growing research in therapeutic products used to treat several diseases are likely to bolster the market demand.

Growing demand for recombinant proteins and molecular replicated products, progress in molecular cloning technology with the advent of innovations, and numerous government policies and support for life science research are the main factors propelling the competent cells market development during the forecast period. The industry is further expected to be driven by the advances in successful research and development on pharmaceutical drugs for treating various diseases, increased government spending on research programmers, and a favorable reimbursement and regulatory environment. As the number of diseases grows, governments in most countries have increased their attention on upgrading healthcare facilities and discovering therapies for specific diseases. As a result, they've expanded their investment in biotechnology firms and simplified regulations to encourage the discovery of therapies for serious diseases.

In the near future, increased investment for DNA cloning technologies studies in academic research centers and using these products in therapeutics is expected to boost the market growth. Increased government and industry investments and the launch of novel product categories are expected to fuel demand growth.

MARKET RESTRAINTS:

The high cost of research and the advanced infrastructure required for the competent cell technique is restraining the growth of the competent cells market. These techniques require a skilled professional, which is also slowing down the growth of the global competent cells market. Due to the need for the cells to stay cold, the process of creating competent cells is challenging. Because the cells are so sensitive and fragile while being made competent, this is essential. Keeping the temperature low throughout processing helps to avoid cell death.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Analysed

By Type, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This market research report on the global competent cells market has been segmented and sub-segmented based on the type, application, and end-user.

Competent Cells Market – By Type:

  • Chemically
  • Electrocompetent

Based on type, chemically competent cells are projected to account for the largest share of the global competent cells market. However, during the forecast period, the electrocompetent cells segment is predicted to rise at the fastest CAGR.

Competent Cells Market – By Application:

  • Cloning     
    • Subcloning & Routine Cloning
    • Phage Display Library Construction
    • Toxic/Unstable DNA Cloning
    • High-Throughput Cloning
  • Protein Expression              
  • Other Applications               
    • Mutagenesis
    • Large Plasmid Transformation
    • Single-Stranded DNA Production
    • Lentiviral Vector Production

Based on the application, the cloning segment dominates the competent cells market. Bacterial transformation is used in DNA cloning, in which the bacteria take up the genetic material. This method is commonly used in molecular biology applications. This sector has grown as a result of the government's increasing support and investments.

Competent Cells Market – By End User:

  • Pharmaceutical Companies
  • Academia

Based on End-User, due to increased research spending in biotechnological applications, the academic research institutes segment is expected to account for the largest share of the market. During the forecast period, the pharmaceutical and biotechnology companies segment is expected to expand the most. The rising investments in research for developing genomics and proteomics-based products are driving this segment's growth.

Competent Cells Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

North America is estimated to constitute the largest share in the global competent cells market. At the same time, the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second-largest shareholder for the market during the forecast period. The Asia-Pacific competent cells market is expected to account for most of the global competent cells market during the forecast period. Extensive studies on DNA cloning technology in the field and the existence of key market players are credited with the development. Because of the developing healthcare and research infrastructure, especially in the region's emerging countries, the Asia-Pacific region is expected to expand significantly.

KEY MARKET PARTICIPANTS:

Some of the prominent companies operating in the global competent cells market profiled in this report are BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), Thermo Fisher Scientific, Inc. (the U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), Bioline (U.K.) and Zymo Research (U.S.).

Recent Market Developments:

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Chemically               

                                5.1.2 Electrocompetent

                                5.1.3  Y-o-Y Growth Analysis, By Type    

                                5.1.4  Market Attractiveness Analysis, By Type  

                                5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

                                5.2.1 Cloning     

                                                5.2.1.1  Subcloning & Routine Cloning

                                                5.2.1.2 Phage Display Library Construction

                                                5.2.1.3 Toxic/Unstable Dna Cloning

                                                5.2.1.4 High-Throughput Cloning

                                5.2.2 Protein Expression              

                                5.2.3 Other Applications               

                                                5.2.3.1 Mutagenesis

                                                5.2.3.2 Large Plasmid Transformation

                                                5.2.3.4 Single-Stranded Dna Production

                                                5.2.3.5 Lentiviral Vector Production

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8  Market Attractiveness Analysis, By Application      

                                5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

                                5.3.1 Pharmaceutical Companies              

                                5.3.2 Academia

                                5.3.3 Y-o-Y Growth Analysis, By EndUser              

                                5.3.4  Market Attractiveness Analysis, By EndUser           

                                5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By EndUser

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By EndUser

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By EndUser

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 BioDynamics Laboratory, Inc. (Japan)                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)                            

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)                              

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)                             

                8.10 Zymo Research (U.S.)                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Competent cells Market By Region, From 2021 to 2026 ( USD Billion )
  2. Global Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  3. Global Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  4. Global Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  5. Global Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  6. Global SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  7. Global Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  8. Global Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  9. Global High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  10. Global  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  11. Global Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  12. Global Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  13. Global Academia Market By Region, From 2021 to 2026 ( USD Billion )
  14. North America Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  15. North America Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  16. North America Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  17. North America Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  18. North America SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  19. North America Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  20. North America Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  21. North America High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  22. North America  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  23. North America Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  24. North America Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  25. North America Academia Market By Region, From 2021 to 2026 ( USD Billion )
  26. United States Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  27. United States Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  28. United States Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  29. Canada Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  30. Canada Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  31. Canada Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  32. Europe Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  33. Europe Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  34. Europe Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  35. Europe Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  36. Europe SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  37. Europe Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  38. Europe Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  39. Europe High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  40. Europe  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  41. Europe Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  42. Europe Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  43. Europe Academia Market By Region, From 2021 to 2026 ( USD Billion )
  44. U.K. Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  45. U.K. Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  46. U.K. Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  47. Germany Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  48. Germany Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  49. Germany Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  50. France Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  51. France Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  52. France Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  53. Italy Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  54. Italy Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  55. Italy Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  56. Spain Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  57. Spain Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  58. Spain Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  59. Asia-Pacific Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  60. Asia-Pacific Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  61. Asia-Pacific Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  62. Asia-Pacific Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  63. Asia-Pacific SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  64. Asia-Pacific Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  65. Asia-Pacific Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  66. Asia-Pacific High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  67. Asia-Pacific  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  68. Asia-Pacific Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  69. Asia-Pacific Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  70. Asia-Pacific Academia Market By Region, From 2021 to 2026 ( USD Billion )
  71. Japan Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  72. Japan Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  73. Japan Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  74. China Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  75. China Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  76. China Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  77. India Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  78. India Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  79. India Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  80. Australia Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  81. Australia Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  82. Australia Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  83. South Korea Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  84. South Korea Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  85. South Korea Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  86. Latin America Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  87. Latin America Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  88. Latin America Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  89. Latin America Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  90. Latin America SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  91. Latin America Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  92. Latin America Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  93. Latin America High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  94. Latin America  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  95. Latin America Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  96. Latin America Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  97. Latin America Academia Market By Region, From 2021 to 2026 ( USD Billion )
  98. Brazil Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  99. Brazil Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  100. Brazil Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  101. Argentina Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  102. Argentina Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  103. Argentina Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  104. Mexico Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  105. Mexico Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  106. Mexico Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  107. Rest of Latin America Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  108. Rest of Latin America Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  109. Rest of Latin America Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  110. Middle East & Africa Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  111. Middle East & Africa Chemically Market By Region, From 2021 to 2026 ( USD Billion )
  112. Middle East & Africa Electro Competent Market By Region, From 2021 to 2026 ( USD Billion )
  113. Middle East & Africa Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  114. Middle East & Africa SubCloning Market By Region, From 2021 to 2026 ( USD Billion )
  115. Middle East & Africa Phage Display Library Production Market By Region, From 2021 to 2026 ( USD Billion )
  116. Middle East & Africa Unstable DNA Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  117. Middle East & Africa High-Throughput Cloning Market By Region, From 2021 to 2026 ( USD Billion )
  118. Middle East & Africa  Mutagenesis Market By Region, From 2021 to 2026 ( USD Billion )
  119. Middle East & Africa Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  120. Middle East & Africa Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  121. Middle East & Africa Academia Market By Region, From 2021 to 2026 ( USD Billion )
  122. Middle East Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  123. Middle East Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  124. Middle East Competent cells Market By End User, From 2021 to 2026 ( USD Billion )
  125. Africa Competent cells Market By Type, From 2021 to 2026 ( USD Billion )
  126. Africa Competent cells Market By Application, From 2021 to 2026 ( USD Billion )
  127. Africa Competent cells Market By End User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample